miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor

The epidermal growth factor receptor (EGFR) is frequently activated in a wide range of solid tumours and represents an important therapeutic target. MicroRNAs (miRNAs) have recently been recognized as a rational and potential modality for anti‐EGFR therapies. However, more EGFR‐targeting miRNAs need...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Qin, Wei, Furong, Zhang, Jianbo, Wang, Xingwu, Li, Baosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891324/
https://www.ncbi.nlm.nih.gov/pubmed/27241841
http://dx.doi.org/10.1111/jcmm.12889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891324/
https://www.ncbi.nlm.nih.gov/pubmed/27241841
http://dx.doi.org/10.1111/jcmm.12889

Ejemplares similares